P3.02c-038 First-Line Atezolizumab plus Chemotherapy in Chemotherapy-Naïve Patients with Advanced NSCLC: A Phase III Clinical Program
Federico Cappuzzo, Martin Reck, Vassiliki A. Papadimitrakopoulou et al. · Journal of Thoracic Oncology · 2017
Cited by 3 works. doi:10.1016/j.jtho.2016.11.1833